You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Opioid receptor antagonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatitis, Acute Trial in Denmark, Sweden (Placebo treatment, Naldemedine 0.2 MG Oral Tablet)

Recruiting
  • Pancreatitis, Acute
  • Placebo treatment
  • Naldemedine 0.2 MG Oral Tablet
  • Aalborg, Jutland, Denmark
  • +4 more
Mar 7, 2022

Opioid Use Disorder, Stimulant Use Disorder Trial in Baltimore (Suvorexant (dual orexin receptor antagonist), Placebo)

Recruiting
  • Opioid Use Disorder
  • Stimulant Use Disorder
  • Suvorexant (dual orexin receptor antagonist)
  • Placebo
  • Baltimore, Maryland
    Behavioral Pharmacology Research Unit at the Johns Hopkins Bayvi
Dec 13, 2022

Alcohol Use Disorder Trial (Detoxification Program, PKAB, CFN)

Not yet recruiting
  • Alcohol Use Disorder
  • Detoxification Program
  • +2 more
  • (no location specified)
Jul 13, 2023

LARS - Low Anterior Resection Syndrome Trial in Seoul (Ramosetron)

Not yet recruiting
  • LARS - Low Anterior Resection Syndrome
  • Seoul, Jongro-gu, Korea, Republic of
    Seoul National University Hospital
Dec 13, 2022

Atopic Dermatitis, Pruritus, Pruritus Chronic Trial in Minneapolis (Naltrexone, Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • +3 more
  • Minneapolis, Minnesota
    University of Minnesota
Feb 25, 2022

Monitoring Drug Efficacy in Patients With Alzheimer's Disease

Recruiting
  • Alzheimer Disease
  • AChE inhibitor monotherapy
  • AChE inhibitor and NMDA receptor antagonist combination therapy
  • Manila, Metro Manila, Philippines
    Philippine General Hospital
Mar 24, 2023

Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)

Recruiting
  • Safety Issues
  • +2 more
  • Washington, District of Columbia
    Georgetown University
Dec 1, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)

Not yet recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • (no location specified)
Feb 2, 2023

Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)

Completed
Has Results
  • Epidermolysis Bullosa
  • Serlopitant Tablet
  • Placebo Oral Tablet
  • Redwood City, California
    Stanford University
Nov 30, 2022

Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

Active, not recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +3 more
Jan 17, 2023

Bladder Cancer, Cystostomy; Complications Trial (Naloxégol oxalate, Placebo oral tablet)

Not yet recruiting
  • Bladder Cancer
  • Cystostomy; Complications
  • Naloxégol oxalate
  • Placebo oral tablet
  • (no location specified)
Jul 27, 2020

Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic Trial in San Francisco, Salisbury (Suvorexant,

Recruiting
  • Sleep Initiation and Maintenance Disorders
  • Stress Disorders, Posttraumatic
  • San Francisco, California
  • +1 more
Nov 10, 2022

Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

Recruiting
  • Rectal Cancer
  • Kineret 100 MG in 0.67 ML Prefilled Syringe
  • +3 more
  • Frankfurt, Germany
    University Hospital Goethe University Frankfurt
Aug 23, 2022

Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)

Not yet recruiting
  • Primary Aldosteronism
  • Hypertension
  • (no location specified)
Apr 3, 2023

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

Not yet recruiting
  • Pericarditis
  • IL1RA Antibody Assay
  • suPAR Testing
  • Homburg, Germany
  • +8 more
Jun 22, 2023

AUD Trial run by the NIAAA (Nalmefene, Placebo)

Recruiting
  • AUD
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 28, 2022

Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)

Not yet recruiting
  • Acute Respiratory Distress Syndrome
  • Placebo
  • Ondansetron Injection
  • Montréal, Quebec, Canada
    Hôpital Sacré-Coeur de Montréal
Aug 22, 2022

Chronic Kidney Diseases Trial (Mineralocorticoid receptor antagonist, Placebo)

Not yet recruiting
  • Chronic Kidney Diseases
  • Mineralocorticoid receptor antagonist
  • Placebo
  • (no location specified)
Sep 21, 2023

Advanced Melanoma Trial in New Brunswick (Propranolol, Naltrexone)

Not yet recruiting
  • Advanced Melanoma
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jul 18, 2023

Depressive Disorder, Major, Anxiety Disorder Trial (Nociceptin Receptor Antagonist, Aversive stimuli)

Not yet recruiting
  • Depressive Disorder, Major
  • Anxiety Disorder
  • Nociceptin Receptor Antagonist
  • Aversive stimuli
  • (no location specified)
Nov 3, 2022

PTSD Trial in San Francisco (CORT108297, Placebo)

Not yet recruiting
  • PTSD
  • San Francisco, California
    San Francisco VA Medical Center, San Francisco, CA
Jul 26, 2022

Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Burns Trial in Shanghai (Cetirizine, Midazolam and Fentanyl)

Recruiting
  • Burns
  • Shanghai, Shanghai, China
    Department of Burn, Ruijin Hospital, Shanghai Jiao Tong Universi
Nov 6, 2023

Exercise, Histamine Trial in Ghent (Placebo: Placebo + exercise training., H1 blockade: H1 receptor antagonist + exercise

Active, not recruiting
  • Exercise
  • Histamine
  • Placebo: Placebo + exercise training.
  • +2 more
  • Ghent, Oost-Vlaanderen, Belgium
    Department of movement and sports sciences, Ghent University, Be
Nov 8, 2022

Rotator Cuff Tendinitis, Chronic Pain Trial in Kristiansund (Ketalar, NaCl 9%)

Recruiting
  • Rotator Cuff Tendinitis
  • Chronic Pain
  • Kristiansund, Norway
    Department of Orthopedic Surgery, Kristiansund Hospital
Mar 15, 2022